Literature DB >> 12512866

Comparative pathology of proliferative lesions of the urinary bladder.

Samuel M Cohen1.   

Abstract

Bladder neoplasia in humans consists of 2 diseases, a low-grade papillary tumor that does not invade or metastasize, and a high-grade lesion that usually invades and metastasizes. Bladder carcinogenesis in rats is most like the low-grade, papillary tumor, although it eventually does progress and invade. In the mouse, models are available that mimic each of these disease processes. Preneoplastic lesions in humans and rodents include various types of hyperplasia, proliferative cystitis, and dysplasia. These preneoplastic and neoplastic lesions arise throughout the urothelium, from the renal pelvis to the urethra, although most commonly in the bladder. Rarely, benign and malignant mesenchymal lesions occur in rats and mice, with a unique submucosal mesenchymal lesion present in some strains of mice. In addition, eosinophilic and clear inclusions in the superficial layer of urothelium in mice, which do not appear to be associated with toxicity or carcinogenesis, have been reported. An approach to evaluation of carcinogenic mechanisms involved in the urothelium is presented. It focuses on distinguishing between DNA reactive carcinogens vs those that act by increasing cell proliferation. Although rodent models do not precisely mimic the human disease, they have provided useful models for furthering our understanding of the carcinogenic process in the urothelium as it pertains to human diseases.

Entities:  

Mesh:

Year:  2002        PMID: 12512866     DOI: 10.1080/01926230290166751

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  19 in total

1.  Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.

Authors:  Haiping Zhou; Hong-ying Huang; Ellen Shapiro; Herbert Lepor; William C Huang; Moosa Mohammadi; Ian Mohr; Moon-shong Tang; Chuanshu Huang; Xue-ru Wu
Journal:  Carcinogenesis       Date:  2012-01-27       Impact factor: 4.944

2.  Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

Authors:  Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

Review 3.  Experimental animal model and RNA interference: a promising association for bladder cancer research.

Authors:  Leonardo Oliveira Reis; Tiago Campos Pereira; Wagner José Favaro; Valéria Helena Alves Cagnon; Iscia Lopes-Cendes; Ubirajara Ferreira
Journal:  World J Urol       Date:  2009-02-13       Impact factor: 4.226

4.  Urothelial endocytic vesicle recycling and lysosomal degradative pathway regulated by lipid membrane composition.

Authors:  E J Grasso; R O Calderón
Journal:  Histochem Cell Biol       Date:  2012-10-12       Impact factor: 4.304

5.  Chemopreventive property of dietary ginger in rat urinary bladder chemical carcinogenesis.

Authors:  Shadia Muhammad Ihlaseh; Maria Luiza Cotrim de Oliveira; Elizabeth Teràn; João Lauro Viana de Camargo; Luís Fernando Barbisan
Journal:  World J Urol       Date:  2006-09-22       Impact factor: 4.226

6.  Rat strains differ in susceptibility to Ureaplasma parvum-induced urinary tract infection and struvite stone formation.

Authors:  Leticia Reyes; Mary Reinhard; L J O'donell; Janet Stevens; Mary B Brown
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

7.  Melatonin prevents the development of hyperplastic urothelium induced by repeated doses of cyclophosphamide.

Authors:  Dasa Zupancic; Gaj Vidmar; Kristijan Jezernik
Journal:  Virchows Arch       Date:  2009-04-21       Impact factor: 4.064

8.  Inhibition of mouse urinary bladder carcinogenesis by açai fruit (Euterpe oleraceae Martius) intake.

Authors:  Mariana F Fragoso; Monize G Prado; Luciano Barbosa; Noeme S Rocha; Luis F Barbisan
Journal:  Plant Foods Hum Nutr       Date:  2012-09       Impact factor: 3.921

9.  Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.

Authors:  Hong-Ying Huang; Shahrokh F Shariat; Tung-Tien Sun; Herbert Lepor; Ellen Shapiro; Jer-Tsong Hsieh; Raheela Ashfaq; Yair Lotan; Xue-Ru Wu
Journal:  Hum Pathol       Date:  2007-08-17       Impact factor: 3.466

Review 10.  Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Authors:  Xue-Ru Wu
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.